<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1 20151215//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName JATS-journalpublishing1.dtd?>
<?SourceDTD.Version 1.1?>
<?ConverterInfo.XSLTName jp2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">PeerJ</journal-id>
    <journal-id journal-id-type="iso-abbrev">PeerJ</journal-id>
    <journal-id journal-id-type="pmc">PeerJ</journal-id>
    <journal-id journal-id-type="publisher-id">PeerJ</journal-id>
    <journal-title-group>
      <journal-title>PeerJ</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2167-8359</issn>
    <publisher>
      <publisher-name>PeerJ Inc.</publisher-name>
      <publisher-loc>San Diego, USA</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">6827457</article-id>
    <article-id pub-id-type="publisher-id">8021</article-id>
    <article-id pub-id-type="doi">10.7717/peerj.8021</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Bioinformatics</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Diabetes and Endocrinology</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Hematology</subject>
      </subj-group>
      <subj-group subj-group-type="heading">
        <subject>Oncology</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>Identification of key genes and long non-coding RNA associated ceRNA networks in hepatocellular carcinoma</article-title>
    </title-group>
    <contrib-group>
      <contrib id="author-1" contrib-type="author">
        <name>
          <surname>Liu</surname>
          <given-names>Jun</given-names>
        </name>
        <xref ref-type="aff" rid="aff-1">1</xref>
        <xref ref-type="aff" rid="aff-2">2</xref>
      </contrib>
      <contrib id="author-2" contrib-type="author">
        <name>
          <surname>Li</surname>
          <given-names>Wenli</given-names>
        </name>
        <xref ref-type="aff" rid="aff-3">3</xref>
      </contrib>
      <contrib id="author-3" contrib-type="author">
        <name>
          <surname>Zhang</surname>
          <given-names>Jian</given-names>
        </name>
        <xref ref-type="aff" rid="aff-1">1</xref>
      </contrib>
      <contrib id="author-4" contrib-type="author">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0001-6530-0539</contrib-id>
        <name>
          <surname>Ma</surname>
          <given-names>Zhanzhong</given-names>
        </name>
        <xref ref-type="aff" rid="aff-1">1</xref>
      </contrib>
      <contrib id="author-5" contrib-type="author">
        <name>
          <surname>Wu</surname>
          <given-names>Xiaoyan</given-names>
        </name>
        <xref ref-type="aff" rid="aff-4">4</xref>
      </contrib>
      <contrib id="author-6" contrib-type="author" corresp="yes">
        <contrib-id contrib-id-type="orcid" authenticated="false">http://orcid.org/0000-0002-9863-3732</contrib-id>
        <name>
          <surname>Tang</surname>
          <given-names>Lirui</given-names>
        </name>
        <xref ref-type="aff" rid="aff-2">2</xref>
        <xref ref-type="aff" rid="aff-5">5</xref>
        <email>tototang6@hotmail.com</email>
      </contrib>
      <aff id="aff-1"><label>1</label><institution>Department of Clinical Laboratory, Yue Bei People’s Hospital</institution>, <addr-line>Shaoguan, Guangdong</addr-line>, <country>China</country></aff>
      <aff id="aff-2"><label>2</label><institution>Morning Star Academic Cooperation</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
      <aff id="aff-3"><label>3</label><institution>Reproductive Medicine Center, Yue Bei People’s Hospital</institution>, <addr-line>Shaoguan, Guangdong</addr-line>, <country>China</country></aff>
      <aff id="aff-4"><label>4</label><institution>Community Healthcare Center</institution>, <addr-line>Shanghai, Shanghai</addr-line>, <country>China</country></aff>
      <aff id="aff-5"><label>5</label><institution>Shanghai JiaoTong University School of Medicine, Shanghai Ninth People’s Hospital</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name>
          <surname>Uversky</surname>
          <given-names>Vladimir</given-names>
        </name>
      </contrib>
    </contrib-group>
    <pub-date pub-type="epub" date-type="pub" iso-8601-date="2019-11-01">
      <day>1</day>
      <month>11</month>
      <year iso-8601-date="2019">2019</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2019</year>
    </pub-date>
    <volume>7</volume>
    <elocation-id>e8021</elocation-id>
    <history>
      <date date-type="received" iso-8601-date="2019-07-08">
        <day>8</day>
        <month>7</month>
        <year iso-8601-date="2019">2019</year>
      </date>
      <date date-type="accepted" iso-8601-date="2019-10-10">
        <day>10</day>
        <month>10</month>
        <year iso-8601-date="2019">2019</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© 2019 Liu et al.</copyright-statement>
      <copyright-year>2019</copyright-year>
      <copyright-holder>Liu et al.</copyright-holder>
      <license xlink:href="https://creativecommons.org/licenses/by/4.0/">
        <license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use, distribution, reproduction and adaptation in any medium and for any purpose provided that it is properly attributed. For attribution, the original author(s), title, publication source (PeerJ) and either DOI or URL of the article must be cited.</license-p>
      </license>
    </permissions>
    <self-uri xlink:href="https://peerj.com/articles/8021"/>
    <abstract>
      <sec>
        <title>Background</title>
        <p>Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related deaths worldwide. Although multiple efforts have been made to understand the development of HCC, morbidity, and mortality rates remain high. In this study, we aimed to discover the mRNAs and long non-coding RNAs (lncRNAs) that contribute to the progression of HCC. We constructed a lncRNA-related competitive endogenous RNA (ceRNA) network to elucidate the molecular regulatory mechanism underlying HCC.</p>
      </sec>
      <sec>
        <title>Methods</title>
        <p>A microarray dataset (<uri xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54238">GSE54238</uri>) containing information about both mRNAs and lncRNAs was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) and lncRNAs (DElncRNAs) in tumor tissues and non-cancerous tissues were identified using the limma package of the R software. The miRNAs that are targeted by DElncRNAs were predicted using miRcode, while the target mRNAs of miRNAs were retrieved from miRDB, miRTarBas, and TargetScan. Functional annotation and pathway enrichment of DEGs were performed using the EnrichNet website. We constructed a protein–protein interaction (PPI) network of DEGs using STRING, and identified the hub genes using Cytoscape. Survival analysis of the hub genes and DElncRNAs was performed using the gene expression profiling interactive analysis database. The expression of molecules with prognostic values was validated on the UALCAN database. The hepatic expression of hub genes was examined using the Human Protein Atlas. The hub genes and DElncRNAs with prognostic values as well as the predictive miRNAs were selected to construct the ceRNA networks.</p>
      </sec>
      <sec>
        <title>Results</title>
        <p>We found that 10 hub genes (KPNA2, MCM7, CKS2, KIF23, HMGB2, ZWINT, E2F1, MCM4, H2AFX, and EZH2) and four lncRNAs (FAM182B, SNHG6, SNHG1, and SNHG3) with prognostic values were overexpressed in the hepatic tumor samples. We also constructed a network containing 10 lncRNA–miRNA–mRNA pathways, which might be responsible for regulating the biological mechanisms underlying HCC.</p>
      </sec>
      <sec>
        <title>Conclusion</title>
        <p>We found that the 10 significantly overexpressed hub genes and four lncRNAs were negatively correlated with the prognosis of HCC. Further, we suggest that lncRNA SNHG1 and the SNHG3-related ceRNAs can be potential research targets for exploring the molecular mechanisms of HCC.</p>
      </sec>
    </abstract>
    <kwd-group kwd-group-type="author">
      <kwd>Hepatocellular carcinoma</kwd>
      <kwd>Competitive endogenous RNAs</kwd>
      <kwd>Prognostic values</kwd>
      <kwd>Molecular biological mechanisms</kwd>
      <kwd>GEO database</kwd>
    </kwd-group>
    <funding-group>
      <funding-statement>The authors received no funding for this work.</funding-statement>
    </funding-group>
  </article-meta>
</front>
<body>
  <sec sec-type="intro">
    <title>Introduction</title>
    <p>Hepatocellular carcinoma (HCC) is the third-largest cause of cancer-related deaths worldwide. There has been an upward trend in the incidence of HCC over recent decades. Importantly, the incidence and mortality of HCC have increased in certain non-traditional high-risk regions such as North America and several European regions. In the United States, HCC has already become the fastest-rising contributor for cancer-related deaths (<xref rid="ref-30" ref-type="bibr">Kulik &amp; El-Serag, 2019</xref>). Several primary diseases, including chronic hepatitis C virus (HCV), hepatitis B virus (HBV), heavy alcohol consumption, and diabetes, have been confirmed as the main risk factors for HCC (<xref rid="ref-43" ref-type="bibr">Singal &amp; El-Serag, 2015</xref>). Due to the high morbidity and mortality as well as the diversity of risk factors associated with HCC, there has been great emphasis on exploring early detection markers, novel therapeutic targets, and prognostic biomarkers. Nevertheless, factors such as high rates of recurrence and metastasis, complexity in treatment and the subsequent rise in financial burden has been a challenge for practitioners globally. Fortunately, the discovery of a variety of non-coding RNAs (ncRNAs), such as lncRNA and miRNA, has facilitated the medical researchers to comprehensively understand HCC.</p>
    <p>Long non-coding RNAs (lncRNAs) belong to a class of RNAs that do not encode for proteins. These RNAs are more than 200 nucleotides in length, and are involved in regulating various cellular processes, such as chromatin remodeling, epigenetic modifications, and protein expression. Dysregulation of lncRNAs has been found to promote tumorigenesis and metastasis and is linked with poor prognosis in HCC (<xref rid="ref-1" ref-type="bibr">Abbastabar et al., 2018</xref>).</p>
    <p>miRNAs are a type of ncRNAs that have been found to be evolutionarily conserved. They are endogenous and have an average length of 22-nt. miRNAs can fine-tune cellular processes in response to physiological and pathological changes by mediating post-transcriptional regulation of the target genes. The dysregulation of miRNAs and the subsequent anomalous interactions with other molecules have profound implications on the initiation, development, and therapy of HCC (<xref rid="ref-3" ref-type="bibr">Borel, Konstantinova &amp; Jansen, 2012</xref>).</p>
    <p>A growing body of evidence has shown that lncRNAs and miRNAs not only affect tumor progression separately but also cooperate with each other in modulating the cancer-related genes or pathways. Specifically, lncRNAs bind to mRNAs preventing their interaction with miRNAs and subsequently inhibit the miRNAs. On the other hand, miRNAs repress their target genes when aberrantly expressed. Therefore, the interaction between three types of RNAs results in the formation of a lncRNA–miRNA–mRNA network, which gives rise to competitive endogenous RNA (ceRNA). The crosstalk mediated by ceRNA assists in coordinating a large number of biological processes (BP). However, in pathological conditions, this can lead to the development of tumorigenesis (<xref rid="ref-28" ref-type="bibr">Karreth &amp; Pandolfi, 2013</xref>).</p>
    <p>In this study, we aimed at exploring the functional significance of lncRNA-related ceRNA networks in HCC based on the ceRNA network theory. We analyzed a microarray dataset containing information about both lncRNA and mRNA obtained from hepatic cancer tissues as well as non-tumor tissues to obtain the DElncRNAs and differentially expressed genes (DEGs). After the target miRNAs of the DElncRNAs as well as the potential upregulated mRNAs of miRNAs were predicted using online tools, the mRNAs that overlapped with the DEGs were selected for further analysis. The DEGs were used to construct a protein–protein interaction (PPI) network complex, and we used this information to identify 10 hub genes. Further, we performed survival analysis on all the hub genes and DElncRNAs. Eventually, 10 hub genes and four DElncRNAs with prognostic values were found to be upregulated in HCC. These hub genes and DElncRNAs as well as the predictive miRNAs were used to construct the ceRNA network.</p>
  </sec>
  <sec sec-type="materials|methods">
    <title>Materials and Methods</title>
    <sec>
      <title>Data acquisition and preprocessing</title>
      <p>The <uri xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54238">GSE54238</uri> expression profile was obtained from the Gene Expression Omnibus (GEO, <uri xlink:href="https://www.ncbi.nlm.nih.gov/geo/">https://www.ncbi.nlm.nih.gov/geo/</uri>), which was imputed on <uri xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/GPL16955">GPL16955</uri> (Arraystar human lncRNA microarray V1-100309) and was found to contain 13 advanced HCC and 10 normal sample tissues. The downloaded raw data were preprocessed, including background adjustment, normalization, and gene biotype re-annotation.</p>
    </sec>
    <sec>
      <title>Acquisition and analysis of expression profiles</title>
      <p>The DElncRNAs and DEGs in the HCC and normal tissues were calculated using the limma package of R software (<uri xlink:href="https://www.r-project.org/">https://www.r-project.org/</uri>). mRNAs with a |log fold change (logFC)| ≥ 1 and an adjusted <italic>P</italic>-value &lt; 0.05 were considered as the selection criteria of DEGs for subsequent analysis. The heat maps of lncRNAs and DEGs were drawn using the pheatmap package of the R software.</p>
    </sec>
    <sec>
      <title>Construction of the ceRNA network</title>
      <p>The interaction of miRNAs with DElncRNAs was predicted based on the file “Highly conserved microRNA families,” which was downloaded from a highly reliable online miRNA reference database, miRcode (<uri xlink:href="http://www.mircode.org/">http://www.mircode.org/</uri>) (<xref rid="ref-23" ref-type="bibr">Jeggari, Marks &amp; Larsson, 2012</xref>). The prediction of target mRNAs of miRNAs was performed using three databases, miRDB (<uri xlink:href="http://www.mirdb.org/">http://www.mirdb.org/</uri>) (<xref rid="ref-52" ref-type="bibr">Wong &amp; Wang, 2015</xref>), miRTarBas (<uri xlink:href="http://mirtarbase.mbc.nctu.edu.tw">http://mirtarbase.mbc.nctu.edu.tw</uri>) (<xref rid="ref-19" ref-type="bibr">Hsu et al., 2014</xref>), and TargetScan (<uri xlink:href="http://www.targetscan.org">http://www.targetscan.org</uri>) (<xref rid="ref-38" ref-type="bibr">Park &amp; Kim, 2013</xref>). We only selected the mRNAs that overlapped with DEGs for constructing the lncRNA–miRNA–mRNA network. The ceRNA network was visualized by Cytoscape (<uri xlink:href="https://cytoscape.org/">https://cytoscape.org/</uri>) (<xref rid="ref-41" ref-type="bibr">Shannon et al., 2003</xref>).</p>
    </sec>
    <sec>
      <title>Functional annotation and pathway enrichment analysis of DEGs</title>
      <p>Differentially expressed genes were analyzed by Gene ontology (GO) and kyoto encyclopedia of genes and genomes (KEGG) analysis on Enrich (<uri xlink:href="http://www.enrichnet.org/">http://www.enrichnet.org/</uri>) website to perform functional annotation and pathway enrichment.</p>
    </sec>
    <sec>
      <title>Construction of the PPI network and screening for the hub genes</title>
      <p>The protein–protein interaction network of the targeted DEGs was constructed using STRING (<uri xlink:href="https://string-db.org/">https://string-db.org/</uri>) and the Cytoscape. The non-interacting genes were excluded in order to simplify the PPI network. The top 10 genes with the highest degree of connection to the others were considered as hub genes based on the analysis using CytoHubba from Cytoscape.</p>
    </sec>
    <sec>
      <title>Reconstruction of the ceRNA network</title>
      <p>The hub genes and DElncRNAs were retrieved using the median value as the cut-off on the Gene Expression Profiling Interactive Analysis (GEPIA, <uri xlink:href="http://gepia.cancer-pku.cn/">http://gepia.cancer-pku.cn/</uri>) website, which is based on The Cancer Genome Atlas. Survival analyses were performed on these newly screened hub genes as well as the lncRNAs to obtain their prognostic values. Then, the hub genes and lncRNAs that showed statistical differences in the survival analysis were used to reconstruct a new ceRNA network. The expression of lncRNAs and hub genes with the most prominent statistical differences in survival was tested and verified using the UALCAN database (<uri xlink:href="http://ualcan.path.uab.edu/">http://ualcan.path.uab.edu/</uri>). The hepatic expression of hub genes was examined using the Human Protein Atlas database (<uri xlink:href="https://www.proteinatlas.org/">https://www.proteinatlas.org/</uri>). Correlation analyses were conducted to analyze the correlations between the expression of each lncRNA and its corresponding hub genes in the ceRNA network on GEPIA.</p>
    </sec>
  </sec>
  <sec sec-type="results">
    <title>Results</title>
    <sec>
      <title>Identification of DElncRNAs and DEGs</title>
      <p>In total, 10 tissue samples from the control and 13 from the HCC tissues were available in the <uri xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54238">GSE54238</uri> dataset. The expression profiles of the mRNAs and lncRNAs were calculated. According to the results analyzed by the limma package, 1,673 mRNAs (<xref ref-type="fig" rid="fig-1">Fig. 1A</xref>) and 12 lncRNAs (<xref ref-type="fig" rid="fig-1">Fig. 1B</xref>) were differentially expressed |(logFC)| ≥ 1 and adjusted <italic>P</italic> &gt; 0.05) and they were defined as DEGs and DElncRNAs, respectively. Out of these, 768 mRNAs and 12 lncRNAs were over-expressed while 904 mRNAs and one lncRNA was downregulated.</p>
      <fig id="fig-1" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.8021/fig-1</object-id>
        <label>Figure 1</label>
        <caption>
          <title>Identification of DElncRNAs and DEGs.</title>
          <p>(A) Volcano plots of the gene expression profile data. The blue dots represent down-regulated genes and the orange dots represent up-regulated genes. (B) Heat map of lncRNAs in HCC samples compared with normal samples.</p>
        </caption>
        <graphic xlink:href="peerj-07-8021-g001"/>
      </fig>
    </sec>
    <sec>
      <title>Construction of the lncRNA-associated ceRNA network</title>
      <p>Based on the results of the online prediction, we found that the miRNAs might interact with DElncRNAs (<xref ref-type="supplementary-material" rid="supp-5">Table S1</xref>). The target mRNAs of the miRNAs are indicated with blue nodes (<xref ref-type="fig" rid="fig-2">Fig. 2</xref>). Among all the predictive mRNAs, only the 126 mRNAs that also existed in the DEGs were selected to construct the first ceRNA network. <xref ref-type="supplementary-material" rid="supp-5">Table S2</xref> shows the details of the 126 mRNAs. The red nodes are DElncRNAs (GAS5, FAM41C, FAM182B, FAM138 B, FAM138C, FAM138D, FAM138E, UCA1, SNHG1, SNHG3, and SNHG6) and the green nodes represent the latently interactive miRNAs.</p>
      <fig id="fig-2" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.8021/fig-2</object-id>
        <label>Figure 2</label>
        <caption>
          <title>lncRNA-associated ceRNA network.</title>
          <p>Red nodes represent the 11 DElncRNAs. Green nodes represent the 32 predictive miRNAs. Blue nodes represent the 126 predictive mRNAs.</p>
        </caption>
        <graphic xlink:href="peerj-07-8021-g002"/>
      </fig>
    </sec>
    <sec>
      <title>Functional annotation and pathway enrichment analysis of DEGs</title>
      <p>In order to thoroughly understand the properties and functions of the 126 DEGs in HCC development and progression, we applied functional annotation and pathway enrichment analysis on each of the DEGs from the ceRNA network. The GO analysis indicated that: (1) for BP, the DEGs from the ceRNA network were particularly enriched in positive regulation of protein localization on the membrane, positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway, positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway, regulation of epithelial cell proliferation, regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay, positive regulation of epithelial to mesenchymal transition, positive regulation of apoptotic processes, positive regulation of nuclear-transcribed mRNA catabolic process, and positive regulation of gene expression (<xref ref-type="fig" rid="fig-3">Fig. 3A</xref>); (2) for cellular components (CC), the DEGs were significantly enriched in chromatin, nuclear chromosomes, nuclear chromatin, apical dendrite, cytoplasmic vesicle membrane, ESC/E(Z) complex, lipid droplet, chromosome, telomeric region, and centrosome (<xref ref-type="fig" rid="fig-3">Fig. 3B</xref>); (3) for molecular functions, the DEGs were enriched in transcription regulatory region DNA binding, core promoter sequence-specific DNA binding, mRNA 3′-UTR AU-rich region binding, regulatory region DNA binding, RNA polymerase II activating transcription factor binding, core promoter binding, cadherin binding, <sc>L</sc>-amino acid transmembrane transporter activity, insulin-like growth factor receptor binding, and amino acid transmembrane transporter activity (<xref ref-type="fig" rid="fig-3">Fig. 3C</xref>). KEGG analysis demonstrated that DEGs were particularly enriched in the cell cycle, microRNAs involved in cancer, central carbon metabolism in cancer, pentose phosphate pathway, PI3K-Akt signaling pathway, fluid shear stress and atherosclerosis, colorectal cancer, non-alcoholic fatty liver disease, small cell lung cancer, and cellular senescence (<xref ref-type="fig" rid="fig-3">Fig. 3D</xref>).</p>
      <fig id="fig-3" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.8021/fig-3</object-id>
        <label>Figure 3</label>
        <caption>
          <title>GO and KEGG analysis of DEGs.</title>
          <p>(A) Biological processes, (B) Cell components, (C) Molecular functions of GO analysis, (D) KEGG analysis.</p>
        </caption>
        <graphic xlink:href="peerj-07-8021-g003"/>
      </fig>
    </sec>
    <sec>
      <title>Construction of the PPI network and identification of the hub genes</title>
      <p>The PPI network complex contained 90 DEGs (<xref ref-type="fig" rid="fig-4">Fig. 4A</xref>). We evaluating their degree of connection, and identified 10 hub genes (MCM4, CKS2, ZWINT, HMGB2, MCM7, KPNA2, E2F1, H2AFX, KIF23, and EZH2), which were all up-regulated in HCC. The hub genes indicated with red nodes (MCM4, ZWINT, MCM7, and KPNA2) had the strongest connections with others, while those indicated with orange (CKS2, HMGB2, KIF23, E2F1) and yellow nodes (EZH2, H2AFX) had moderate and weak connections, respectively (<xref ref-type="fig" rid="fig-4">Fig. 4B</xref>).</p>
      <fig id="fig-4" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.8021/fig-4</object-id>
        <label>Figure 4</label>
        <caption>
          <title>PPI network of DEGs and hub genes.</title>
          <p>(A) PPI network of DEGs. Blue nodes represent the interaction among DEGs. Only the 90 DEGs that interacting with other ones were demonstrated in the network. (B) A total of 10 Hub genes identified from the PPI network. From the red nodes to yellow ones, the connection degree of each molecule with others gradually decreases.</p>
        </caption>
        <graphic xlink:href="peerj-07-8021-g004"/>
      </fig>
    </sec>
    <sec>
      <title>Survival analysis of hub genes and DElncRNAs</title>
      <p>We performed survival analysis on the hub genes and DElncRNAs and found that 10 overexpressed hub genes (MCM4, MCM7, ZWINT, KPNA2, CKS2, KIF23, E2F1, HMGB2, EZH2, and H2AFX) were significantly related to poorer prognosis with worse survival times in HCC patients. Among these, KPNA2 and EZH2 had the highest prognostic value (<xref ref-type="fig" rid="fig-5">Fig. 5</xref>). We used the information from the ICGC database to validate our analyses, and found them to be consistent with our results (<xref ref-type="supplementary-material" rid="supp-3">Fig. S1</xref>). Four DElncRNAs (FAM182B, SNHG1, SNHG3, and SNHG6) were upregulated and were found to be negatively related to the prognosis of HCC, with SNHG3 having the best clinical predictive value (<xref ref-type="fig" rid="fig-6">Fig. 6</xref>).</p>
      <fig id="fig-5" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.8021/fig-5</object-id>
        <label>Figure 5</label>
        <caption>
          <title>Overall survival analysis of the hub genes.</title>
          <p>(A) MCM4. (B) MCM7. (C) ZWINT. (D) KPNA2. (E) CKS2. (F) KIF23. (G) E2F1. (H) HMGB2. (I) EZH2. (J) H2AFX. The overall survival of patients with highly expressed hub genes was significantly shorter than those with low expression.</p>
        </caption>
        <graphic xlink:href="peerj-07-8021-g005"/>
      </fig>
      <fig id="fig-6" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.8021/fig-6</object-id>
        <label>Figure 6</label>
        <caption>
          <title>Overall survival analysis of the DElncRNAs.</title>
          <p>(A) FAM182B. (B) SNHG1. (C) SNHG3. (D) SNHG6. The overall survival of patients with highly expressed DElncRNAs was significantly shorter than those with low expression.</p>
        </caption>
        <graphic xlink:href="peerj-07-8021-g006"/>
      </fig>
    </sec>
    <sec>
      <title>Validation of the expression of hub genes and DElncRNAs</title>
      <p>Expression of the hub genes, as well as the DElncRNAs with prognostic significance, was tested using the UALCAN database in order to verify the differences in expression. Consistent with the results described before, all of the DElncRNAs (<xref ref-type="fig" rid="fig-7">Fig. 7</xref>) and hub genes (<xref ref-type="fig" rid="fig-8">Fig. 8</xref>) with prognostic significance were significantly overexpressed in HCC tissues compared with normal ones. Further details of the comparisons are shown in <xref ref-type="supplementary-material" rid="supp-5">Table S3</xref>. In addition, comparative analysis of the hub genes from the ICGC database was consistent with that obtained from the UALCAN database (<xref ref-type="supplementary-material" rid="supp-4">Fig. S2</xref>). Furthermore, hepatic expressions of the hub genes (MCM4, MCM7, ZWINT, KPNA2, CKS2, KIF23, E2F1, HMGB2, EZH2, and H2AFX) were visualized using immunohistochemistry based on the Human Protein Atlas. While MCM4, MCM7, and EZH2 were not detected in non-tumor tissues, they were moderately or highly expressed in tumor tissues. The genes, ZWINT, E2F1, HMGB2, KPNA2, and CKS2, were expressed at low or moderate levels in non-tumor tissues. However, the staining intensity or the range of positive distribution of all the other proteins increased in tumor samples, except for KPNA2 (<xref ref-type="fig" rid="fig-9">Fig. 9</xref>).</p>
      <fig id="fig-7" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.8021/fig-7</object-id>
        <label>Figure 7</label>
        <caption>
          <title>Validation of lncRNA expression in UALCAN database.</title>
          <p>(A) FAM182B. (B) SNHG1. (C) SNHG3. (D) SNHG6. Based on UALCAN, all DElncRNAs were significantly overexpressed in HCC tissues compared with the normal ones.</p>
        </caption>
        <graphic xlink:href="peerj-07-8021-g007"/>
      </fig>
      <fig id="fig-8" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.8021/fig-8</object-id>
        <label>Figure 8</label>
        <caption>
          <title>Validation of hub genes expression in UALCAN database.</title>
          <p>(A) MCM4. (B) MCM7. (C) ZWINT. (D) KPNA2. (E) CKS2. (F) KIF23. (G) E2F1. (H) HMGB2. (I) EZH2. (J) H2AFX. Based on UALCAN, all hub genes were significantly overexpressed in HCC tissues compared with the normal ones.</p>
        </caption>
        <graphic xlink:href="peerj-07-8021-g008"/>
      </fig>
      <fig id="fig-9" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.8021/fig-9</object-id>
        <label>Figure 9</label>
        <caption>
          <title>Validation of hepatic expression of hub genes in the Human Protein Atlas database.</title>
          <p>Expression of (A) MCM4, (C) KIF23, (E) MCM7, (G) E2F1, (I) ZWINT, (K) HMGB2, (M) KPNA2, (O) EZH2, (Q) CKS2, (S) H2AFX in non-tumor tissues. Expression of (B) MCM4, (D) KIF23, (F) MCM7, (H) E2F1, (J) ZWINT, (L) HMGB2, (N) KPNA2, (P) EZH2, (R) CKS2, (T) H2AFX in tumor tissues. Proteins encoded by MCM4, MCM7, ZWINT, CKS2, E2FI, HMGB2, and EZH2 were expressed higher in tumor than in non-tumor tissues. KPNA2 were expressed moderately in both groups. KIF23 and H2AFX were highly expressed in both tumor and non-tumor tissues.</p>
        </caption>
        <graphic xlink:href="peerj-07-8021-g009"/>
      </fig>
    </sec>
    <sec>
      <title>Reconstruction of the lncRNA-associated ceRNA network</title>
      <p>The newly screened hub genes and DElncRNAs were used to reconstruct a new ceRNA network. In total, 10 hub genes (KPNA2, MCM7, CKS2, KIF23, HMGB2, ZWINT, E2F1, MCM4, H2AFX, and EZH2), seven miRNAs (hsa-miR-107, hsa-miR-1297, hsa-miR-24-3p, hsa-miR-216b-5p, hsa-miR-217, hsa-miR-338-3p, and hsa-miR-107) and four lncRNAs (FAM182B, SNHG6, SNHG1, and SNHG3) were included (<xref ref-type="fig" rid="fig-10">Fig. 10</xref>). The reconstructed network consisted of 10 lncRNA–miRNA–mRNA pathways, including FAM182B-hsa-miR-107-KIF23, FAM182B-hsa-miR-107-MCM7, SNHG6-hsa-miR-1297-KPNA2, SNHG6-hsa-miR-1297-CKS2, SNHG6-hsa-miR-24-3p-H2AFX, SNHG3-hsa-miR-338-3p-ZWINT, SNHG1-hsa-miR-217-EZH2, SNHG1-hsa-miR-23b-3p-HMGB2, SNHG1-hsa-miR-216b-5p-E2F1, and SNHG1-hsa-miR-216b-5p-MCM4 (<xref rid="table-1" ref-type="table">Table 1</xref>). lncRNA SNHG1 had the highest number of connections with the hub genes.</p>
      <fig id="fig-10" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.8021/fig-10</object-id>
        <label>Figure 10</label>
        <caption>
          <title>The lncRNA–miRNA–mRNA ceRNA network constructed from hub genes and DElncRNAs.</title>
          <p>Red nodes represent lncRNAs. Green nodes represent miRNAs. Blue nodes represent hub genes. A total of 10 lncRNA–miRNA–mRNA pathways were reconstructed here.</p>
        </caption>
        <graphic xlink:href="peerj-07-8021-g010"/>
      </fig>
      <table-wrap id="table-1" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.8021/table-1</object-id>
        <label>Table 1</label>
        <caption>
          <title>Reconstruction of the lncRNA-associated ceRNA networks.</title>
        </caption>
        <alternatives>
          <graphic xlink:href="peerj-07-8021-g012"/>
          <table frame="hsides" rules="groups" content-type="text">
            <colgroup span="1">
              <col span="1"/>
              <col span="1"/>
              <col span="1"/>
            </colgroup>
            <thead>
              <tr>
                <th rowspan="1" colspan="1">lncRNA</th>
                <th rowspan="1" colspan="1">miRNA</th>
                <th rowspan="1" colspan="1">mRNA</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">SNHG1</td>
                <td rowspan="1" colspan="1">has-miR-216b-5P</td>
                <td rowspan="1" colspan="1">E2F1</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1">MCM4</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1">hsa-miR-217</td>
                <td rowspan="1" colspan="1">EZH2</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1">has-miR-23b-3P</td>
                <td rowspan="1" colspan="1">HMGB2</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">SNHG6</td>
                <td rowspan="1" colspan="1">has-miR-1297</td>
                <td rowspan="1" colspan="1">KPNA2</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1">CKS2</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1">has-miR-24-3P</td>
                <td rowspan="1" colspan="1">H2AFX</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">FAM182B</td>
                <td rowspan="1" colspan="1">hsa-miR-107</td>
                <td rowspan="1" colspan="1">MCM7</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1"/>
                <td rowspan="1" colspan="1">KIF23</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">SNHG3</td>
                <td rowspan="1" colspan="1">has-miR-338-3P</td>
                <td rowspan="1" colspan="1">ZWINT</td>
              </tr>
            </tbody>
          </table>
        </alternatives>
      </table-wrap>
    </sec>
    <sec>
      <title>Co-expression analysis of lncRNAs and hub genes from the ceRNA network</title>
      <p>Correlation analyses showed that expressions of all the lncRNAs were correlated with that of their corresponding mRNAs (<xref ref-type="fig" rid="fig-11">Figs. 11A</xref>–<xref ref-type="fig" rid="fig-11">11F</xref>). SNHG1 had the strongest correlations with its hub genes as the correlation coefficient for E2F1, EZH2, HMGB2, and MCM4 being 0.67, 0.77, 0.72, and 0.7, respectively (<xref ref-type="fig" rid="fig-11">Figs. 11C</xref>–<xref ref-type="fig" rid="fig-11">11F</xref>). All of these indicate a strong correlation. SNHG3, the lncRNA with the most valuable clinical significance, also showed a strong correlation with ZWINT (<italic>R</italic> = 0.6, <xref ref-type="fig" rid="fig-11">Fig. 11G</xref>). In terms of expression, FAM182B and SNHG6 were moderately related to their corresponding mRNAs with correlation coefficients ranging from 0.51 to 0.67.</p>
      <fig id="fig-11" orientation="portrait" position="float">
        <object-id pub-id-type="doi">10.7717/peerj.8021/fig-11</object-id>
        <label>Figure 11</label>
        <caption>
          <title>Co-expression analysis of DElncRNAs from ceRNA network with related hub genes in HCC patients.</title>
          <p>(A) lncRNA FAM182B with KIF23. (B) lncRNA FAM182B with MCM7. (C) lncRNA SNHG1 with E2F1. (D) lncRNA SNHG1 with EZH2. (E) lncRNA SNHG1 with HMGB2. (F) lncRNA SNHG1 with MCM4. (G) lncRNA SNHG3 with ZWINT. (H) lncRNA SNHG6 with CKS2. (I) lncRNA SNHG6 with H2AFX. (J) lncRNA SNHG6 with KPNA2. SNHG1 and SNHG3 were strongly correlatted with their hub genes. FAM182B and SNHG6 showed moderate correlation with corresponding hub genes.</p>
        </caption>
        <graphic xlink:href="peerj-07-8021-g011"/>
      </fig>
    </sec>
  </sec>
  <sec sec-type="discussion">
    <title>Discussion</title>
    <p>In this study, 10 hub genes and four lncRNAs were found to be overexpressed in HCC tissues. Meanwhile, survival analysis results confirmed that they were potential candidates for prognostic predictions in HCC patients. Among all the hub genes, KPNA2 and EZH2, which are tumor-promoting genes, have been extensively studied and were found to be the most effective predictors of survival time. SNHG3, a lncRNA that is relatively less known, had the highest predictive value for clinical HCC prognosis.</p>
    <p>None of the hub genes were completely new in the field of HCC. It has been shown that HCC patients who had higher expression of KPNA2 in the nucleus have poorer prognosis and higher risk of recurrence (<xref rid="ref-25" ref-type="bibr">Jiang et al., 2014b</xref>). KPNA2 imparts proliferative and metastatic abilities to the HCC cells by aiding the entry of certain transcriptional factors, such as PLAG2, into the nucleus (<xref rid="ref-20" ref-type="bibr">Hu et al., 2014</xref>). MCM7 has been identified as a prognostic marker of HCC that promotes cell proliferation and tumorigenicity by suppressing cyclin D1 expression via the activation of the MAPK pathway. Through this mechanism, MCM7 initiates DNA replication, which is a key process in cell cycle progression (<xref rid="ref-39" ref-type="bibr">Qu et al., 2017</xref>). CKS2 is activated by the Wnt/β-catenin signaling pathway and promotes cell proliferation and inhibits apoptosis, which makes the HCC cells more aggressive as its overexpression is more frequently observed in poorly differentiated tumors (<xref rid="ref-34" ref-type="bibr">Li et al., 2018</xref>; <xref rid="ref-42" ref-type="bibr">Shen et al., 2010</xref>). KIF23 depletion inhibits tumor formation by inducing apoptosis in certain types of cancer, such as lung adenocarcinomas. However, there are diverse clinical research reports on HCC that contradict our results. According to a previous study, KIF23, which has two splice variants, V1 and V2, is overexpressed in HCC tissues, while it is almost undetectable in normal tissues. Patients with positive V1 expression, which is mainly located inside the nucleus, have better overall 5-year survival than those with negative results. However, KIF23 V2 had no correlation with overall survival (OS). Therefore, further in-depth studies should be undertaken to evaluate the function of KIF23 in HCC (<xref rid="ref-46" ref-type="bibr">Sun et al., 2015</xref>). HMGB2 overexpression was detected at both mRNA and protein levels in tumor tissues from HCC patients. It is associated with shorter OS, and is considered to be an independent prognostic factor. In an in vitro study, HMGB2 was found to promote HCC cell proliferation and impair drug sensitivity (<xref rid="ref-31" ref-type="bibr">Kwon et al., 2010</xref>). ZWINT protein is elevated in HCC tissues and shows correlation with tumor size and number. HCC patients with high expression of ZWINT tend to experience higher rates of tumor recurrence. ZWINT may enhance cell proliferation by disturbing the expression of cell cycle-related proteins, such as proliferating cell nuclear antigen (PCNA) and cyclin B1, which results in shorter OS (<xref rid="ref-59" ref-type="bibr">Ying et al., 2018</xref>). E2F1 protein is activated to a greater extent in tumor tissues compared to that in the normal liver or adjacent non-tumor tissues from the same HCC patients (<xref rid="ref-13" ref-type="bibr">Feng et al., 2015</xref>). In mice with copy number gains in E2F1, dosage-dependent spontaneous tumors only occurred in the liver, which indicates that E2F1 is specifically involved in the promotion of hepatic tumorigenesis (<xref rid="ref-29" ref-type="bibr">Kent et al., 2017</xref>). The survival analysis from another dataset, <uri xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE14520">GSE14520</uri>, supported our results, which showed that MCM4 enrichment had significant association with the OS in HCC patients in the background of hepatitis B infection (<xref rid="ref-35" ref-type="bibr">Liao et al., 2018</xref>). H2AFX is upregulated and activated in HCC, as shown by the increase in the levels of total and phosphorylated H2AFX in tumor tissues (<xref rid="ref-11" ref-type="bibr">Evert et al., 2013</xref>). In addition, H2AFX together with another seven genes, constitutes a prognostic signature for HCC with C-indexes of 0.776, 0.745, and 0.789 for 1-, 3-, and 5-year OS, respectively (<xref rid="ref-63" ref-type="bibr">Zhang et al., 2019a</xref>). EZH2 is important in determining the character of hepatic tumors and immunohistochemistry results showed that this protein was positively stained in various types of malignant liver tumors. However, EZH2 has not been detected in benign hepatic diseases, such as adenomas or cirrhotic nodules (<xref rid="ref-15" ref-type="bibr">Hajósi-Kalcakosz et al., 2012</xref>). By inhibiting the natural killer cell-mediated eradication of tumor cells, EZH2 may create an immune microenvironment that is conducive to HCC cells (<xref rid="ref-5" ref-type="bibr">Bugide, Green &amp; Wajapeyee, 2018</xref>).</p>
    <p>We also constructed a lncRNA-related ceRNA network consisting of 10 possible lncRNA–miRNA–mRNA pathways with DEGs and DElncRNAs, in which the DElncRNAs might compete with the DEGs for binding to their target miRNAs. Through this process, the DElncRNAs can regulate the expression and function of DEGs without directly interacting with them. In all the pathways, lncRNA SNHG1 might potentially regulate most of the hub genes, including EZH2, HMGB2, E2F1, and MCM4. It is worth noting that our results demonstrated a close correlation between the expression of SHNG1 and the four mRNAs, which strengthens the possibility of mutual regulation between them. Since all the mRNAs and lncRNAs in this network originated from the same dataset, we believed the predictive regulatory relationships are convincing, and are worth investigating further.</p>
    <p>SNHG3 was found to be overexpressed in HCC tissues as compared to normal hepatic samples in this study. In addition, lncRNA SNHG3 was the most valuable prognostic factor for HCC. Consistent with our finding, SNHG3 expression has been proven to be negatively associated with the OS, recurrence-free survival and disease-free survival in HCC patients (<xref rid="ref-62" ref-type="bibr">Zhang et al., 2016a</xref>). SNHG3 promotes metastasis and induces sorafenib resistance by inducing EMT via the miR-128/CD151 pathway in HCC cells (<xref rid="ref-67" ref-type="bibr">Zhang et al., 2019b</xref>). Although there have been no research investigations on the direct interactions between SNHG3 and its targeting miRNAs in HCC, several studies have found that SNHG3 forms a ceRNA network by sponging miRNAs in other cancers (<xref rid="ref-7" ref-type="bibr">Chen, Wu &amp; Zhang, 2019</xref>; <xref rid="ref-21" ref-type="bibr">Huang et al., 2017</xref>; <xref rid="ref-50" ref-type="bibr">Wang et al., 2019</xref>; <xref rid="ref-69" ref-type="bibr">Zheng et al., 2019</xref>). For example, SNHG3 sponged miRNA-151a-3p (<xref rid="ref-69" ref-type="bibr">Zheng et al., 2019</xref>) and miR-196a-5p (<xref rid="ref-7" ref-type="bibr">Chen, Wu &amp; Zhang, 2019</xref>) in order to promote cell growth, invasion, and migration in osteosarcoma.</p>
    <p>miR-338-3p is downregulated in HCC and inhibits its progression in various ways including suppressing cell proliferation (<xref rid="ref-14" ref-type="bibr">Fu et al., 2012</xref>), countering Warburg effects (<xref rid="ref-37" ref-type="bibr">Nie et al., 2015</xref>) as well as inhibiting metastasis (<xref rid="ref-6" ref-type="bibr">Chen et al., 2017</xref>; <xref rid="ref-65" ref-type="bibr">Zhang et al., 2016b</xref>). A diverse array of molecules, such as mineralocorticoid receptors (<xref rid="ref-37" ref-type="bibr">Nie et al., 2015</xref>), HBV X (<xref rid="ref-14" ref-type="bibr">Fu et al., 2012</xref>), and circular RNAs (circRNA) (<xref rid="ref-33" ref-type="bibr">Li et al., 2019</xref>) have been validated as the direct upstream regulators of miR-338-3p in HCC. A novel mechanism indicating that miR-338-3p expression might be regulated by lncRNA SNHG3 has been identified. The downstream binding targets of miR-338-3p, including N-cadherin (<xref rid="ref-6" ref-type="bibr">Chen et al., 2017</xref>), MACC1 (<xref rid="ref-65" ref-type="bibr">Zhang et al., 2016b</xref>), HIF-1α (<xref rid="ref-55" ref-type="bibr">Xu et al., 2014</xref>), and CyclinD1 (<xref rid="ref-14" ref-type="bibr">Fu et al., 2012</xref>) have also been well studied in HCC. However, for the first time, this study has predicted ZWINT as a potential target of miR-338-3p.</p>
    <p>ZWINT is upregulated in HCC samples as well as cell lines, and promotes cell proliferation by affecting the expression of cell-cycle proteins, such as PCNA, cyclin, and CDK1 (<xref rid="ref-59" ref-type="bibr">Ying et al., 2018</xref>). ZWINT has also been identified as a key biomarker in drug-induced liver injury, which indicates its possible involvement in drug metabolism (<xref rid="ref-9" ref-type="bibr">Cho et al., 2016</xref>). However, a study conducted in post-surgery HCC patients showed that ZWINT expression was decreased in tumor samples (<xref rid="ref-57" ref-type="bibr">Yang et al., 2018b</xref>). These contradictory results could be due to the different stages of the disease when these studies were carried out, and due to the diverse causes that lead to development of HCC. Several miRNAs, such as miR-127-3p and miR-1, have been found to directly or potentially target ZWINT and promote tumor progression (<xref rid="ref-24" ref-type="bibr">Jiang et al., 2014a</xref>; <xref rid="ref-53" ref-type="bibr">Xie et al., 2018</xref>). Here, we identified ZWINT as a target of miR-338-3p that might form a ceRNA network with lncRNA SNHG3 in HCC.</p>
    <p>In this study, we found that lncRNA SNHG1 was negatively associated with HCC prognosis. This result is consistent with previous research, which showed that overexpression of SNHG1 correlated with larger tumor size, poor differentiation degree, and a worse clinical-stage (<xref rid="ref-66" ref-type="bibr">Zhang et al., 2016c</xref>). SNHG1 also had the most number of connections with the hub genes, which means that it can most likely regulate the expression of the four mRNAs found in this network through miRNAs. SNHG1 was found to exacerbate HCC by inhibiting miR-195 directly (<xref rid="ref-68" ref-type="bibr">Zhang et al., 2016d</xref>). However, to our knowledge, this study has reported for the first time that in HCC, hsa-miR-217, has-miR-216b-5p, and hsa-miR-23b-3p might be the other targets of SNHG1.</p>
    <p>In HCC, decreased miR-217 expression is positively associated with vascular invasion, and TNM stage (<xref rid="ref-49" ref-type="bibr">Tian et al., 2017</xref>). miR-217 partially inhibits hepatic metastasis by binding to the 3′-UTR of MTDH mRNA (<xref rid="ref-44" ref-type="bibr">Su et al., 2014</xref>; <xref rid="ref-64" ref-type="bibr">Zhang et al., 2017</xref>), which encodes a protein that can induce cell growth and inhibit apoptosis (<xref rid="ref-32" ref-type="bibr">Li et al., 2015</xref>). However, miR-217 was also found to be overexpressed in HCC and is potentially involved in promoting hepatic disease (<xref rid="ref-26" ref-type="bibr">Jiang et al., 2017</xref>). miR-217 induces cancer stem cell-like phenotypes resulting in the activation of the Wnt pathway in HCC cells (<xref rid="ref-26" ref-type="bibr">Jiang et al., 2017</xref>). High miR-217 levels leads to fat deposition in hepatocytes (<xref rid="ref-58" ref-type="bibr">Yin et al., 2012</xref>). These conflicting results may be attributed to the difference in the cell lines used in the experiments and the different stages of the disease when the studies were conducted.</p>
    <p>miR-216b-5p is an anti-tumor miRNA found in several cancers (<xref rid="ref-17" ref-type="bibr">He et al., 2019</xref>; <xref rid="ref-40" ref-type="bibr">Ren et al., 2019</xref>; <xref rid="ref-48" ref-type="bibr">Sun et al., 2019b</xref>; <xref rid="ref-60" ref-type="bibr">You et al., 2017</xref>). It is believed that miR-216b-5p inhibits HCV by suppressing host autophagy (<xref rid="ref-22" ref-type="bibr">Huang et al., 2018</xref>). Paradoxically, miR-216b-5p represses the expression of UDP-glucuronosyltransferase 2B, a group of enzymes that detoxifies carcinogens by binding to their 3′UTRs (<xref rid="ref-10" ref-type="bibr">Dluzen et al., 2016</xref>). In addition, few other studies have also explored how miR-216b-5p affects HCC progression.</p>
    <p>Low hepatic miR-23b-3p expression is considered as a biomarker of HCC tumorigenesis and progression (<xref rid="ref-18" ref-type="bibr">He et al., 2018</xref>). Meanwhile, serum miR-23b-3p levels help in distinguishing between the HCV patients that are at high risk of progressing to HCC from those with low risk (<xref rid="ref-47" ref-type="bibr">Sun et al., 2019a</xref>). Mechanically, miR-23b-3p inhibits the epithelial-mesenchymal transition in HCC cells via sponging by lncRNA HOTAIR from ZEB1 (<xref rid="ref-56" ref-type="bibr">Yang et al., 2018a</xref>). Although it has been speculated that miR-23b-3p is also involved in fat metabolism, the conclusions are inconsistent. A study found that in HepG2 cells, miR-23b-3p inhibits the synthesis of ApoA protein, which is a risk factor for thrombotic diseases (<xref rid="ref-61" ref-type="bibr">Zeng et al., 2018</xref>), whereas another study reported that SIRT1, an enzyme that prevents lipid accumulation, was repressed by hsa-miR-23b-3p in hepatocytes (<xref rid="ref-4" ref-type="bibr">Borji et al., 2019</xref>).</p>
    <p>Among all the mRNAs in the SNHG1-related ceRNA network, EZH2, a widely investigated oncogene, is highly expressed in HCC tissues and contributes to its progression (<xref rid="ref-45" ref-type="bibr">Sudo et al., 2005</xref>). Similar to the results in this study, EZH2 has been validated as a direct target of miR-217 in gastric cancer cells (<xref rid="ref-8" ref-type="bibr">Chen et al., 2015</xref>). Nevertheless, a study conducted in colorectal cancer cells has found that EZH2 promotes cell growth by directly binding to lncRNA SNHG1 without requiring mediation of miRNAs (<xref rid="ref-54" ref-type="bibr">Xu et al., 2018</xref>). This suggests that EZH2 expression might be regulated by SNHG1 through various pathways.</p>
    <p>In HCC, the HMGB2 mRNA is overexpressed and serves as an independent prognostic factor for OS (<xref rid="ref-31" ref-type="bibr">Kwon et al., 2010</xref>). Similar to our predictive analysis, HMGB2 was found to promote gastric cancer cell autophagy and induce multidrug resistance by directly interacting with miR-23b-3p (<xref rid="ref-2" ref-type="bibr">An et al., 2015</xref>).</p>
    <p>E2F1 is a transcription factor that has been known to promote HCC progression (<xref rid="ref-12" ref-type="bibr">Farra et al., 2017</xref>). Besides the findings in this study, miR-331-3p (<xref rid="ref-27" ref-type="bibr">Jin et al., 2019</xref>) and miR-34a (<xref rid="ref-16" ref-type="bibr">Han et al., 2019</xref>) have also been found to regulate E2F1 expression in HCC cell lines. However, precise interactions between E2F1 and miRNAs need further exploration.</p>
    <p>MCM4 expression is inversely related to the OS in HBV-related HCC (<xref rid="ref-35" ref-type="bibr">Liao et al., 2018</xref>). The gene polymorphism of MCM4 also affects the chances of developing HCC as the patients who carry the MCM4 rs2305952 CC are less likely to have the disease (<xref rid="ref-36" ref-type="bibr">Nan et al., 2016</xref>). The regulatory mechanism of MCM4 in HCC has been barely explored as there is only one previous study reporting MCM4 as a latent target of miR-122-5p (<xref rid="ref-51" ref-type="bibr">Wen et al., 2018</xref>). The results of this study provide novel information that might aid further investigation.</p>
    <p>In summary, we identified 10 mRNAs and four lncRNAs that may promote HCC progression. We also constructed the –-miRNA–mRNA ceRNA network in order to understand the latent regulatory mechanism between mRNAs and ncRNAs. The lncRNA SNHG1 and SNHG3-related ceRNAs can be selected as novel targets while exploring the molecular mechanism of HCC.</p>
  </sec>
  <sec sec-type="conclusions">
    <title>Conclusions</title>
    <p>In this study, we identified 10 significantly overexpressed hub genes (MCM4, CKS2, ZWINT, HMGB2, MCM7, KPNA2, E2F1, H2AFX, KIF23, and EZH2) and four lncRNAs (FAM182B, SNHG1, SNHG3, and SNHG6) and found them to be negatively correlated with HCC prognosis. We also suggested that the lncRNA SNHG1 and SNHG3-related ceRNAs can be potential research targets for investigating the molecular mechanism of HCC.</p>
  </sec>
  <sec sec-type="supplementary-material" id="supplemental-information">
    <title>Supplemental Information</title>
    <supplementary-material content-type="local-data" id="supp-1">
      <object-id pub-id-type="doi">10.7717/peerj.8021/supp-1</object-id>
      <label>Supplemental Information 1</label>
      <caption>
        <title>Code used for difference analysis.</title>
      </caption>
      <media xlink:href="peerj-07-8021-s001.r">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-2">
      <object-id pub-id-type="doi">10.7717/peerj.8021/supp-2</object-id>
      <label>Supplemental Information 2</label>
      <caption>
        <title>Code used for biotype.</title>
      </caption>
      <media xlink:href="peerj-07-8021-s002.pl">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-3">
      <object-id pub-id-type="doi">10.7717/peerj.8021/supp-3</object-id>
      <label>Supplemental Information 3</label>
      <caption>
        <title>Validation of hub genes expression in ICGC database.</title>
        <p>(A) MCM4. (B) MCM7. (C) ZWINT. (D) KPNA2. (E) CKS2. (F) KIF23. (G) E2F1. (H) HMGB2. (I) EZH2. (J) H2AFX. All hub genes were significantly up-regulated in tumor tissues than in normal ones.</p>
      </caption>
      <media xlink:href="peerj-07-8021-s003.png">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-4">
      <object-id pub-id-type="doi">10.7717/peerj.8021/supp-4</object-id>
      <label>Supplemental Information 4</label>
      <caption>
        <title>Overall survival analysis of the hub genes from ICGC database.</title>
        <p>(A) MCM4. (B) MCM7. (C) ZWINT. (D) KPNA2. (E) CKS2. (F) KIF23. (G) E2F1. (H) HMGB2. (I) EZH2. (J) H2AFX. HCC patients with high expression of any of the hub genes had shorter overall survival time.</p>
      </caption>
      <media xlink:href="peerj-07-8021-s004.png">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
    <supplementary-material content-type="local-data" id="supp-5">
      <object-id pub-id-type="doi">10.7717/peerj.8021/supp-5</object-id>
      <label>Supplemental Information 5</label>
      <caption>
        <title>Supplemental Tables.</title>
      </caption>
      <media xlink:href="peerj-07-8021-s005.docx">
        <caption>
          <p>Click here for additional data file.</p>
        </caption>
      </media>
    </supplementary-material>
  </sec>
</body>
<back>
  <sec sec-type="additional-information">
    <title>Additional Information and Declarations</title>
    <fn-group content-type="competing-interests">
      <title>Competing Interests</title>
      <fn fn-type="COI-statement" id="conflict-1">
        <p>The authors declare that they have no competing interests.</p>
      </fn>
    </fn-group>
    <fn-group content-type="author-contributions">
      <title>Author Contributions</title>
      <fn fn-type="con" id="contribution-1">
        <p><xref ref-type="contrib" rid="author-1">Jun Liu</xref> conceived and designed the experiments, performed the experiments, analyzed the data, prepared figures and/or tables, approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-2">
        <p><xref ref-type="contrib" rid="author-2">Wenli Li</xref> conceived and designed the experiments, performed the experiments, prepared figures and/or tables, approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-3">
        <p><xref ref-type="contrib" rid="author-3">Jian Zhang</xref> analyzed the data, contributed reagents/materials/analysis tools, prepared figures and/or tables, authored or reviewed drafts of the paper, approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-4">
        <p><xref ref-type="contrib" rid="author-4">Zhanzhong Ma</xref> analyzed the data, contributed reagents/materials/analysis tools, authored or reviewed drafts of the paper, approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-5">
        <p><xref ref-type="contrib" rid="author-5">Xiaoyan Wu</xref> analyzed the data, contributed reagents/materials/analysis tools, authored or reviewed drafts of the paper, approved the final draft.</p>
      </fn>
      <fn fn-type="con" id="contribution-6">
        <p><xref ref-type="contrib" rid="author-6">Lirui Tang</xref> conceived and designed the experiments, authored or reviewed drafts of the paper, approved the final draft.</p>
      </fn>
    </fn-group>
    <fn-group content-type="other">
      <title>Data Availability</title>
      <fn id="addinfo-1">
        <p>The following information was supplied regarding data availability:</p>
        <p>The lncRNAs and mRNAs expression profile are available at the GEO database: <uri xlink:href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE54238">GSE54238</uri>.</p>
        <p>The code is available in the <xref ref-type="supplementary-material" rid="supplemental-information">Supplemental Files</xref>.</p>
      </fn>
    </fn-group>
  </sec>
  <ref-list content-type="authoryear">
    <title>References</title>
    <ref id="ref-1">
      <label>Abbastabar et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Abbastabar</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sarfi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Golestani</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Khalili</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>lncRNA involvement in hepatocellular carcinoma metastasis and prognosis</article-title>
        <source>EXCLI Journal</source>
        <year>2018</year>
        <volume>17</volume>
        <fpage>900</fpage>
        <lpage>913</lpage>
        <pub-id pub-id-type="doi">10.17179/excli2018-1541</pub-id>
        <pub-id pub-id-type="pmid">30564069</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-2">
      <label>An et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>An</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Shang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Nie</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Q</given-names>
          </name>
        </person-group>
        <article-title>miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2</article-title>
        <source>Cell Death &amp; Disease</source>
        <year>2015</year>
        <volume>6</volume>
        <issue>5</issue>
        <elocation-id>e1766</elocation-id>
        <pub-id pub-id-type="doi">10.1038/cddis.2015.123</pub-id>
        <pub-id pub-id-type="pmid">25996293</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-3">
      <label>Borel, Konstantinova &amp; Jansen (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Borel</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Konstantinova</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Jansen</surname>
            <given-names>PLM</given-names>
          </name>
        </person-group>
        <article-title>Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma</article-title>
        <source>Journal of Hepatology</source>
        <year>2012</year>
        <volume>56</volume>
        <issue>6</issue>
        <fpage>1371</fpage>
        <lpage>1383</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jhep.2011.11.026</pub-id>
        <pub-id pub-id-type="pmid">22314424</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-4">
      <label>Borji et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Borji</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nourbakhsh</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shafiee</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Owji</surname>
            <given-names>AA</given-names>
          </name>
          <name>
            <surname>Abdolvahabi</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Hesari</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Ilbeigi</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Seiri</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Yousefi</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Down-regulation of SIRT1 expression by mir-23b contributes to lipid accumulation in HepG2 cells</article-title>
        <source>Biochemical Genetics</source>
        <year>2019</year>
        <volume>57</volume>
        <issue>4</issue>
        <fpage>507</fpage>
        <lpage>521</lpage>
        <pub-id pub-id-type="doi">10.1007/s10528-019-09905-5</pub-id>
        <pub-id pub-id-type="pmid">30697640</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-5">
      <label>Bugide, Green &amp; Wajapeyee (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bugide</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Green</surname>
            <given-names>MR</given-names>
          </name>
          <name>
            <surname>Wajapeyee</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Inhibition of enhancer of zeste homolog 2 (EZH2) induces natural killer cell-mediated eradication of hepatocellular carcinoma cells</article-title>
        <source>Proceedings of the National Academy of Sciences of the United States of America</source>
        <year>2018</year>
        <volume>115</volume>
        <issue>15</issue>
        <fpage>E3509</fpage>
        <lpage>E3518</lpage>
        <pub-id pub-id-type="doi">10.1073/pnas.1802691115</pub-id>
        <pub-id pub-id-type="pmid">29581297</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-6">
      <label>Chen et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>JS</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>LL</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>HX</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>SL</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>LZ</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Bi</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>WT</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>XH</given-names>
          </name>
        </person-group>
        <article-title>miR-338-3p inhibits epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma cells</article-title>
        <source>Oncotarget</source>
        <year>2017</year>
        <volume>8</volume>
        <issue>42</issue>
        <fpage>71418</fpage>
        <lpage>71429</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.10138</pub-id>
        <pub-id pub-id-type="pmid">29069716</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-7">
      <label>Chen, Wu &amp; Zhang (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma</article-title>
        <source>International Journal of Immunopathology and Pharmacology</source>
        <year>2019</year>
        <volume>33</volume>
        <issue>1</issue>
        <fpage>2058738418820743</fpage>
        <pub-id pub-id-type="doi">10.1177/2058738418820743</pub-id>
        <pub-id pub-id-type="pmid">30791797</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-8">
      <label>Chen et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>DL</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>YX</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>LZ</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>ZL</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>FH</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>YH</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>HZ</given-names>
          </name>
          <name>
            <surname>Pelicano</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>RH</given-names>
          </name>
        </person-group>
        <article-title>microRNA-217 inhibits tumor progression and metastasis by downregulating EZH2 and predicts favorable prognosis in gastric cancer</article-title>
        <source>Oncotarget</source>
        <year>2015</year>
        <volume>6</volume>
        <issue>13</issue>
        <fpage>10868</fpage>
        <lpage>10879</lpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.3451</pub-id>
        <pub-id pub-id-type="pmid">25869101</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-9">
      <label>Cho et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cho</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Na</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Jo</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>Meta-analysis method for discovering reliable biomarkers by integrating statistical and biological approaches: an application to liver toxicity</article-title>
        <source>Biochemical and Biophysical Research Communications</source>
        <year>2016</year>
        <volume>471</volume>
        <issue>2</issue>
        <fpage>274</fpage>
        <lpage>281</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbrc.2016.01.082</pub-id>
        <pub-id pub-id-type="pmid">26820531</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-10">
      <label>Dluzen et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dluzen</surname>
            <given-names>DF</given-names>
          </name>
          <name>
            <surname>Sutliff</surname>
            <given-names>AK</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Watson</surname>
            <given-names>CJW</given-names>
          </name>
          <name>
            <surname>Ishmael</surname>
            <given-names>FT</given-names>
          </name>
          <name>
            <surname>Lazarus</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Regulation of UGT2B expression and activity by miR-216b-5p in liver cancer cell lines</article-title>
        <source>Journal of Pharmacology and Experimental Therapeutics</source>
        <year>2016</year>
        <volume>359</volume>
        <issue>1</issue>
        <fpage>182</fpage>
        <lpage>193</lpage>
        <pub-id pub-id-type="doi">10.1124/jpet.116.235044</pub-id>
        <pub-id pub-id-type="pmid">27474751</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-11">
      <label>Evert et al. (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Evert</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Frau</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Tomasi</surname>
            <given-names>ML</given-names>
          </name>
          <name>
            <surname>Latte</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Simile</surname>
            <given-names>MM</given-names>
          </name>
          <name>
            <surname>Seddaiu</surname>
            <given-names>MA</given-names>
          </name>
          <name>
            <surname>Zimmermann</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ladu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Staniscia</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Brozzetti</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Solinas</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Dombrowski</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Feo</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Pascale</surname>
            <given-names>RM</given-names>
          </name>
          <name>
            <surname>Calvisi</surname>
            <given-names>DF</given-names>
          </name>
        </person-group>
        <article-title>Deregulation of DNA-dependent protein kinase catalytic subunit contributes to human hepatocarcinogenesis development and has a putative prognostic value</article-title>
        <source>British Journal of Cancer</source>
        <year>2013</year>
        <volume>109</volume>
        <issue>10</issue>
        <fpage>2654</fpage>
        <lpage>2664</lpage>
        <pub-id pub-id-type="doi">10.1038/bjc.2013.606</pub-id>
        <pub-id pub-id-type="pmid">24136149</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-12">
      <label>Farra et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Farra</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Grassi</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Tonon</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Abrami</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Grassi</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Pozzato</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Fiotti</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Forte</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Dapas</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>The role of the transcription factor E2F1 in hepatocellular carcinoma</article-title>
        <source>Current Drug Delivery</source>
        <year>2017</year>
        <volume>14</volume>
        <issue>2</issue>
        <fpage>272</fpage>
        <lpage>281</lpage>
        <pub-id pub-id-type="doi">10.2174/1567201813666160527141742</pub-id>
        <pub-id pub-id-type="pmid">27109336</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-13">
      <label>Feng et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Feng</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>Y-Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>MS</given-names>
          </name>
          <name>
            <surname>Go</surname>
            <given-names>MYY</given-names>
          </name>
          <name>
            <surname>Cheung</surname>
            <given-names>Y-S</given-names>
          </name>
          <name>
            <surname>Lai</surname>
            <given-names>PBS</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>AML</given-names>
          </name>
          <name>
            <surname>To</surname>
            <given-names>K-F</given-names>
          </name>
          <name>
            <surname>Chan</surname>
            <given-names>HLY</given-names>
          </name>
          <name>
            <surname>Sung</surname>
            <given-names>JJY</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>ASL</given-names>
          </name>
        </person-group>
        <article-title>A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patients</article-title>
        <source>Journal of Hepatology</source>
        <year>2015</year>
        <volume>62</volume>
        <issue>5</issue>
        <fpage>1100</fpage>
        <lpage>1111</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jhep.2014.11.040</pub-id>
        <pub-id pub-id-type="pmid">25500144</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-14">
      <label>Fu et al. (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hou</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>miR-338-3p is down-regulated by hepatitis B virus X and inhibits cell proliferation by targeting the 3′-UTR region of CyclinD1</article-title>
        <source>International Journal of Molecular Sciences</source>
        <year>2012</year>
        <volume>13</volume>
        <issue>7</issue>
        <fpage>8514</fpage>
        <lpage>8539</lpage>
        <pub-id pub-id-type="doi">10.3390/ijms13078514</pub-id>
        <pub-id pub-id-type="pmid">22942717</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-15">
      <label>Hajósi-Kalcakosz et al. (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hajósi-Kalcakosz</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Dezső</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Bugyik</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Bödör</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Paku</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Pávai</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Halász</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Schlachter</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Schaff</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Nagy</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>Enhancer of zeste homologue 2 (EZH2) is a reliable immunohistochemical marker to differentiate malignant and benign hepatic tumors</article-title>
        <source>Diagnostic Pathology</source>
        <year>2012</year>
        <volume>7</volume>
        <issue>1</issue>
        <fpage>86</fpage>
        <pub-id pub-id-type="doi">10.1186/1746-1596-7-86</pub-id>
        <pub-id pub-id-type="pmid">22809481</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-16">
      <label>Han et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Han</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating <italic>E2F1</italic>, <italic>E2F3</italic>, and Caspase-3</article-title>
        <source>Cancer Management and Research</source>
        <year>2019</year>
        <volume>11</volume>
        <fpage>2963</fpage>
        <lpage>2976</lpage>
        <pub-id pub-id-type="doi">10.2147/CMAR.S202664</pub-id>
        <pub-id pub-id-type="pmid">31114344</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-17">
      <label>He et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>He</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Geng</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Long non-coding RNA Linc00518 promotes paclitaxel resistance of the human prostate cancer by sequestering miR-216b-5p</article-title>
        <source>Biology of the Cell</source>
        <year>2019</year>
        <volume>111</volume>
        <issue>2</issue>
        <fpage>39</fpage>
        <lpage>50</lpage>
        <pub-id pub-id-type="doi">10.1111/boc.201800054</pub-id>
        <pub-id pub-id-type="pmid">30462844</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-18">
      <label>He et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>He</surname>
            <given-names>R-Q</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>P-R</given-names>
          </name>
          <name>
            <surname>Xiang</surname>
            <given-names>X-L</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>H-W</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>X-H</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>L-H</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>Z-G</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Downregulated miR-23b-3p expression acts as a predictor of hepatocellular carcinoma progression: a study based on public data and RT-qPCR verification</article-title>
        <source>International Journal of Molecular Medicine</source>
        <year>2018</year>
        <volume>41</volume>
        <fpage>2813</fpage>
        <lpage>2831</lpage>
        <pub-id pub-id-type="doi">10.3892/ijmm.2018.3513</pub-id>
        <pub-id pub-id-type="pmid">29484429</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-19">
      <label>Hsu et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hsu</surname>
            <given-names>S-D</given-names>
          </name>
          <name>
            <surname>Tseng</surname>
            <given-names>Y-T</given-names>
          </name>
          <name>
            <surname>Shrestha</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Khaleel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>C-H</given-names>
          </name>
          <name>
            <surname>Chu</surname>
            <given-names>C-F</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H-Y</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>C-M</given-names>
          </name>
          <name>
            <surname>Ho</surname>
            <given-names>S-Y</given-names>
          </name>
          <name>
            <surname>Jian</surname>
            <given-names>T-Y</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>F-M</given-names>
          </name>
          <name>
            <surname>Chang</surname>
            <given-names>T-H</given-names>
          </name>
          <name>
            <surname>Weng</surname>
            <given-names>S-L</given-names>
          </name>
          <name>
            <surname>Liao</surname>
            <given-names>K-W</given-names>
          </name>
          <name>
            <surname>Liao</surname>
            <given-names>I-E</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C-C</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>H-D</given-names>
          </name>
        </person-group>
        <article-title>miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions</article-title>
        <source>Nucleic Acids Research</source>
        <year>2014</year>
        <volume>42</volume>
        <issue>D1</issue>
        <fpage>D78</fpage>
        <lpage>D85</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gkt1266</pub-id>
        <pub-id pub-id-type="pmid">24304892</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-20">
      <label>Hu et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>Z-Y</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>S-X</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>W-P</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Pleomorphic adenoma gene 1 mediates the role of karyopherin alpha 2 and has prognostic significance in hepatocellular carcinoma</article-title>
        <source>Journal of Experimental &amp; Clinical Cancer Research</source>
        <year>2014</year>
        <volume>33</volume>
        <issue>1</issue>
        <fpage>61</fpage>
        <pub-id pub-id-type="doi">10.1186/s13046-014-0061-1</pub-id>
        <pub-id pub-id-type="pmid">25060425</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-21">
      <label>Huang et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Tian</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Cha</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yuan</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>The long non-coding RNA SNHG3 functions as a competing endogenous RNA to promote malignant development of colorectal cancer</article-title>
        <source>Oncology Reports</source>
        <year>2017</year>
        <volume>38</volume>
        <issue>3</issue>
        <fpage>1402</fpage>
        <lpage>1410</lpage>
        <pub-id pub-id-type="doi">10.3892/or.2017.5837</pub-id>
        <pub-id pub-id-type="pmid">28731158</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-22">
      <label>Huang et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Huang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Pei</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Cheng</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Transduction with lentiviral vectors altered the expression profile of host MicroRNAs</article-title>
        <source>Journal of Virology</source>
        <year>2018</year>
        <volume>92</volume>
        <issue>18</issue>
        <fpage>e00503-18</fpage>
        <pub-id pub-id-type="doi">10.1128/JVI.00503-18</pub-id>
        <pub-id pub-id-type="pmid">29997205</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-23">
      <label>Jeggari, Marks &amp; Larsson (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jeggari</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Marks</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Larsson</surname>
            <given-names>E</given-names>
          </name>
        </person-group>
        <article-title>miRcode: a map of putative microRNA target sites in the long non-coding transcriptome</article-title>
        <source>Bioinformatics</source>
        <year>2012</year>
        <volume>28</volume>
        <issue>15</issue>
        <fpage>2062</fpage>
        <lpage>2063</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bts344</pub-id>
        <pub-id pub-id-type="pmid">22718787</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-24">
      <label>Jiang et al. (2014a)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Hua</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Lou</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Lan</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Yoon</surname>
            <given-names>J-G</given-names>
          </name>
          <name>
            <surname>Zheng</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>B</given-names>
          </name>
        </person-group>
        <article-title>Next generation sequencing analysis of miRNAs: MiR-127-3p inhibits glioblastoma proliferation and activates TGF-β signaling by targeting SKI</article-title>
        <source>OMICS: A Journal of Integrative Biology</source>
        <year>2014a</year>
        <volume>18</volume>
        <issue>3</issue>
        <fpage>196</fpage>
        <lpage>206</lpage>
        <pub-id pub-id-type="doi">10.1089/omi.2013.0122</pub-id>
        <pub-id pub-id-type="pmid">24517116</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-25">
      <label>Jiang et al. (2014b)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mai</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Aberrant expression of nuclear KPNA2 is correlated with early recurrence and poor prognosis in patients with small hepatocellular carcinoma after hepatectomy</article-title>
        <source>Medical Oncology</source>
        <year>2014b</year>
        <volume>31</volume>
        <issue>8</issue>
        <fpage>131</fpage>
        <pub-id pub-id-type="doi">10.1007/s12032-014-0131-4</pub-id>
        <pub-id pub-id-type="pmid">25031071</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-26">
      <label>Jiang et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jiang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Xie</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ren</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Kuang</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>miR-217 targeting DKK1 promotes cancer stem cell properties via activation of the Wnt signaling pathway in hepatocellular carcinoma</article-title>
        <source>Oncology Reports</source>
        <year>2017</year>
        <volume>38</volume>
        <issue>4</issue>
        <fpage>2351</fpage>
        <lpage>2359</lpage>
        <pub-id pub-id-type="doi">10.3892/or.2017.5924</pub-id>
        <pub-id pub-id-type="pmid">28849121</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-27">
      <label>Jin et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Jin</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhong</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title><italic>MiR-331-3p</italic> inhibition of the hepatocellular carcinoma (HCC) Bel-7402 cell line by down-regulation of E2F1</article-title>
        <source>Journal of Nanoscience and Nanotechnology</source>
        <year>2019</year>
        <volume>19</volume>
        <issue>9</issue>
        <fpage>5476</fpage>
        <lpage>5482</lpage>
        <pub-id pub-id-type="doi">10.1166/jnn.2019.16535</pub-id>
        <pub-id pub-id-type="pmid">30961699</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-28">
      <label>Karreth &amp; Pandolfi (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Karreth</surname>
            <given-names>FA</given-names>
          </name>
          <name>
            <surname>Pandolfi</surname>
            <given-names>PP</given-names>
          </name>
        </person-group>
        <article-title>ceRNA cross-talk in cancer: when ce-bling rivalries go awry</article-title>
        <source>Cancer Discovery</source>
        <year>2013</year>
        <volume>3</volume>
        <issue>10</issue>
        <fpage>1113</fpage>
        <lpage>1121</lpage>
        <pub-id pub-id-type="doi">10.1158/2159-8290.CD-13-0202</pub-id>
        <pub-id pub-id-type="pmid">24072616</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-29">
      <label>Kent et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kent</surname>
            <given-names>LN</given-names>
          </name>
          <name>
            <surname>Bae</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Tsai</surname>
            <given-names>S-Y</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Srivastava</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Koivisto</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Martin</surname>
            <given-names>CK</given-names>
          </name>
          <name>
            <surname>Ridolfi</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>GC</given-names>
          </name>
          <name>
            <surname>Zorko</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Plevris</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Hadjiyannis</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Perez</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Nolan</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Kladney</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Westendorp</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>De Bruin</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Fernandez</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Rosol</surname>
            <given-names>TJ</given-names>
          </name>
          <name>
            <surname>Pohar</surname>
            <given-names>KS</given-names>
          </name>
          <name>
            <surname>Pipas</surname>
            <given-names>JM</given-names>
          </name>
          <name>
            <surname>Leone</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma</article-title>
        <source>Journal of Clinical Investigation</source>
        <year>2017</year>
        <volume>127</volume>
        <issue>3</issue>
        <fpage>830</fpage>
        <lpage>842</lpage>
        <pub-id pub-id-type="doi">10.1172/JCI87583</pub-id>
        <pub-id pub-id-type="pmid">28134624</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-30">
      <label>Kulik &amp; El-Serag (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kulik</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>El-Serag</surname>
            <given-names>HB</given-names>
          </name>
        </person-group>
        <article-title>Epidemiology and management of hepatocellular carcinoma</article-title>
        <source>Gastroenterology</source>
        <year>2019</year>
        <volume>156</volume>
        <issue>2</issue>
        <fpage>477</fpage>
        <lpage>491.e1</lpage>
        <pub-id pub-id-type="doi">10.1053/j.gastro.2018.08.065</pub-id>
        <pub-id pub-id-type="pmid">30367835</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-31">
      <label>Kwon et al. (2010)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Kwon</surname>
            <given-names>J-H</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>SM</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>CW</given-names>
          </name>
          <name>
            <surname>Hong</surname>
            <given-names>SJ</given-names>
          </name>
          <name>
            <surname>Park</surname>
            <given-names>SY</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>YJ</given-names>
          </name>
          <name>
            <surname>Do</surname>
            <given-names>I-G</given-names>
          </name>
          <name>
            <surname>Joh</surname>
            <given-names>J-W</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>DS</given-names>
          </name>
          <name>
            <surname>Choi</surname>
            <given-names>KY</given-names>
          </name>
        </person-group>
        <article-title>Overexpression of high-mobility group box 2 is associated with tumor aggressiveness and prognosis of hepatocellular carcinoma</article-title>
        <source>Clinical Cancer Research</source>
        <year>2010</year>
        <volume>16</volume>
        <issue>22</issue>
        <fpage>5511</fpage>
        <lpage>5521</lpage>
        <pub-id pub-id-type="doi">10.1158/1078-0432.CCR-10-0825</pub-id>
        <pub-id pub-id-type="pmid">20851854</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-32">
      <label>Li et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>W-F</given-names>
          </name>
          <name>
            <surname>Ou</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C-A</given-names>
          </name>
        </person-group>
        <article-title>Lentiviral-mediated short hairpin RNA knockdown of MTDH inhibits cell growth and induces apoptosis by regulating the PTEN/AKT pathway in hepatocellular carcinoma</article-title>
        <source>International Journal of Molecular Sciences</source>
        <year>2015</year>
        <volume>16</volume>
        <issue>8</issue>
        <fpage>19419</fpage>
        <lpage>19432</lpage>
        <pub-id pub-id-type="doi">10.3390/ijms160819419</pub-id>
        <pub-id pub-id-type="pmid">26287185</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-33">
      <label>Li et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Deng</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Circular RNA MAT2B promotes glycolysis and malignancy of hepatocellular carcinoma through the miR-338-3p/PKM2 axis under hypoxic stress</article-title>
        <source>Hepatology</source>
        <year>2019</year>
        <volume>70</volume>
        <issue>4</issue>
        <fpage>1298</fpage>
        <lpage>1316</lpage>
        <pub-id pub-id-type="doi">10.1002/hep.30671</pub-id>
        <pub-id pub-id-type="pmid">31004447</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-34">
      <label>Li et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>T-Q</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>X-L</given-names>
          </name>
          <name>
            <surname>Ni</surname>
            <given-names>C-F</given-names>
          </name>
        </person-group>
        <article-title>EGFL7 promotes hepatocellular carcinoma cell proliferation and inhibits cell apoptosis through increasing CKS2 expression by activating Wnt/β-catenin signaling</article-title>
        <source>Journal of Cellular Biochemistry</source>
        <year>2018</year>
        <volume>119</volume>
        <issue>12</issue>
        <fpage>10327</fpage>
        <lpage>10337</lpage>
        <pub-id pub-id-type="doi">10.1002/jcb.27375</pub-id>
        <pub-id pub-id-type="pmid">30129142</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-35">
      <label>Liao et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liao</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Qin</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Deng</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Ye</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Peng</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Distinct diagnostic and prognostic values of minichromosome maintenance gene expression in patients with hepatocellular carcinoma</article-title>
        <source>Journal of Cancer</source>
        <year>2018</year>
        <volume>9</volume>
        <issue>13</issue>
        <fpage>2357</fpage>
        <lpage>2373</lpage>
        <pub-id pub-id-type="doi">10.7150/jca.25221</pub-id>
        <pub-id pub-id-type="pmid">30026832</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-36">
      <label>Nan et al. (2016)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nan</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>Y-L</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Z-K</given-names>
          </name>
          <name>
            <surname>Duan</surname>
            <given-names>F-F</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>D-F</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>X-Y</given-names>
          </name>
        </person-group>
        <article-title>Relationships between cell cycle pathway gene polymorphisms and risk of hepatocellular carcinoma</article-title>
        <source>World Journal of Gastroenterology</source>
        <year>2016</year>
        <volume>22</volume>
        <issue>24</issue>
        <fpage>5558</fpage>
        <lpage>5567</lpage>
        <pub-id pub-id-type="doi">10.3748/wjg.v22.i24.5558</pub-id>
        <pub-id pub-id-type="pmid">27350734</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-37">
      <label>Nie et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Nie</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>X-M</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>Q-Z</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>M-X</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Qin</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Gu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Xia</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z-G</given-names>
          </name>
        </person-group>
        <article-title>Mineralocorticoid receptor suppresses cancer progression and the Warburg effect by modulating the miR-338-3p-PKLR axis in hepatocellular carcinoma</article-title>
        <source>Hepatology</source>
        <year>2015</year>
        <volume>62</volume>
        <issue>4</issue>
        <fpage>1145</fpage>
        <lpage>1159</lpage>
        <pub-id pub-id-type="doi">10.1002/hep.27940</pub-id>
        <pub-id pub-id-type="pmid">26082033</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-38">
      <label>Park &amp; Kim (2013)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Park</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kim</surname>
            <given-names>K-B</given-names>
          </name>
        </person-group>
        <article-title>miRTar hunter: a prediction system for identifying human microRNA target sites</article-title>
        <source>Molecules and Cells</source>
        <year>2013</year>
        <volume>35</volume>
        <issue>3</issue>
        <fpage>195</fpage>
        <lpage>201</lpage>
        <pub-id pub-id-type="doi">10.1007/s10059-013-2165-4</pub-id>
        <pub-id pub-id-type="pmid">23475422</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-39">
      <label>Qu et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Qu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Fan</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>An</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Dong</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>MCM7 promotes cancer progression through cyclin D1-dependent signaling and serves as a prognostic marker for patients with hepatocellular carcinoma</article-title>
        <source>Cell Death &amp; Disease</source>
        <year>2017</year>
        <volume>8</volume>
        <issue>2</issue>
        <elocation-id>e2603</elocation-id>
        <pub-id pub-id-type="doi">10.1038/cddis.2016.352</pub-id>
        <pub-id pub-id-type="pmid">28182015</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-40">
      <label>Ren et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ren</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Guan</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Pyridoxine 5′-phosphate oxidase is correlated with human breast invasive ductal carcinoma development</article-title>
        <source>Aging</source>
        <year>2019</year>
        <volume>11</volume>
        <issue>7</issue>
        <fpage>2151</fpage>
        <lpage>2176</lpage>
        <pub-id pub-id-type="doi">10.18632/aging.101908</pub-id>
        <pub-id pub-id-type="pmid">30982780</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-41">
      <label>Shannon et al. (2003)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shannon</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Markiel</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ozier</surname>
            <given-names>O</given-names>
          </name>
          <name>
            <surname>Baliga</surname>
            <given-names>NS</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>JT</given-names>
          </name>
          <name>
            <surname>Ramage</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Amin</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Schwikowski</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ideker</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Cytoscape: a software environment for integrated models of biomolecular interaction networks</article-title>
        <source>Genome Research</source>
        <year>2003</year>
        <volume>13</volume>
        <issue>11</issue>
        <fpage>2498</fpage>
        <lpage>2504</lpage>
        <pub-id pub-id-type="doi">10.1101/gr.1239303</pub-id>
        <pub-id pub-id-type="pmid">14597658</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-42">
      <label>Shen et al. (2010)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Shen</surname>
            <given-names>D-Y</given-names>
          </name>
          <name>
            <surname>Fang</surname>
            <given-names>Z-X</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>P-G</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>C-L</given-names>
          </name>
          <name>
            <surname>Yao</surname>
            <given-names>X-B</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Z-X</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z-Y</given-names>
          </name>
        </person-group>
        <article-title>Clinical significance and expression of cyclin kinase subunits 1 and 2 in hepatocellular carcinoma</article-title>
        <source>Liver International</source>
        <year>2010</year>
        <volume>30</volume>
        <issue>1</issue>
        <fpage>119</fpage>
        <lpage>125</lpage>
        <pub-id pub-id-type="doi">10.1111/j.1478-3231.2009.02106.x</pub-id>
        <pub-id pub-id-type="pmid">19845855</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-43">
      <label>Singal &amp; El-Serag (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Singal</surname>
            <given-names>AG</given-names>
          </name>
          <name>
            <surname>El-Serag</surname>
            <given-names>HB</given-names>
          </name>
        </person-group>
        <article-title>Hepatocellular carcinoma from epidemiology to prevention: translating knowledge into practice</article-title>
        <source>Clinical Gastroenterology and Hepatology</source>
        <year>2015</year>
        <volume>13</volume>
        <issue>12</issue>
        <fpage>2140</fpage>
        <lpage>2151</lpage>
        <pub-id pub-id-type="doi">10.1016/j.cgh.2015.08.014</pub-id>
        <pub-id pub-id-type="pmid">26284591</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-44">
      <label>Su et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Su</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhong</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>miR-217 inhibits invasion of hepatocellular carcinoma cells through direct suppression of E2F3</article-title>
        <source>Molecular and Cellular Biochemistry</source>
        <year>2014</year>
        <volume>392</volume>
        <issue>1–2</issue>
        <fpage>289</fpage>
        <lpage>296</lpage>
        <pub-id pub-id-type="doi">10.1007/s11010-014-2039-x</pub-id>
        <pub-id pub-id-type="pmid">24671492</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-45">
      <label>Sudo et al. (2005)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sudo</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Utsunomiya</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Mimori</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Nagahara</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Ogawa</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Inoue</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wakiyama</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Fujita</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Shirouzu</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Mori</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Clinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma</article-title>
        <source>British Journal of Cancer</source>
        <year>2005</year>
        <volume>92</volume>
        <issue>9</issue>
        <fpage>1754</fpage>
        <lpage>1758</lpage>
        <pub-id pub-id-type="doi">10.1038/sj.bjc.6602531</pub-id>
        <pub-id pub-id-type="pmid">15856046</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-46">
      <label>Sun et al. (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Qian</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>Evaluation of KIF23 variant 1 expression and relevance as a novel prognostic factor in patients with hepatocellular carcinoma</article-title>
        <source>BMC Cancer</source>
        <year>2015</year>
        <volume>15</volume>
        <issue>1</issue>
        <fpage>961</fpage>
        <pub-id pub-id-type="doi">10.1186/s12885-015-1987-1</pub-id>
        <pub-id pub-id-type="pmid">26674738</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-47">
      <label>Sun et al. (2019a)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Jin</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Gu</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Evaluation of miR-331-3p and miR-23b-3p as serum biomarkers for hepatitis c virus-related hepatocellular carcinoma at early stage</article-title>
        <source>Clinics and Research in Hepatology and Gastroenterology</source>
        <year>2019a</year>
        <pub-id pub-id-type="doi">10.1016/j.clinre.2019.03.011</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-48">
      <label>Sun et al. (2019b)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sun</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Luan</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Long noncoding RNA LINC00265 promotes glycolysis and lactate production of colorectal cancer through regulating of miR-216b-5p/TRIM44 axis</article-title>
        <source>Digestion</source>
        <year>2019b</year>
        <fpage>1</fpage>
        <lpage>10</lpage>
        <pub-id pub-id-type="doi">10.1159/000500195</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-49">
      <label>Tian et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tian</surname>
            <given-names>YW</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>QF</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>YX</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Xue</surname>
            <given-names>HZ</given-names>
          </name>
        </person-group>
        <article-title>Decreased levels of miR-34a and miR-217 act as predictor biomarkers of aggressive progression and poor prognosis in hepatocellular carcinoma</article-title>
        <source>Minerva Medica</source>
        <year>2017</year>
        <volume>108</volume>
        <issue>2</issue>
        <fpage>108</fpage>
        <lpage>113</lpage>
        <pub-id pub-id-type="doi">10.23736/S0026-4806.16.04616-4</pub-id>
        <pub-id pub-id-type="pmid">27879964</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-50">
      <label>Wang et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>D</given-names>
          </name>
        </person-group>
        <article-title>LncRNA SNHG3 regulates laryngeal carcinoma proliferation and migration by modulating the miR-384/WEE1 axis</article-title>
        <source>Life Sciences</source>
        <year>2019</year>
        <volume>232</volume>
        <fpage>116597</fpage>
        <pub-id pub-id-type="doi">10.1016/j.lfs.2019.116597</pub-id>
        <pub-id pub-id-type="pmid">31238052</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-51">
      <label>Wen et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wen</surname>
            <given-names>DY</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>JY</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>WY</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>JH</given-names>
          </name>
          <name>
            <surname>Pang</surname>
            <given-names>YY</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>Potential clinical value and putative biological function of miR-122-5p in hepatocellular carcinoma: a comprehensive study using microarray and RNA sequencing data</article-title>
        <source>Oncology Letters</source>
        <year>2018</year>
        <volume>16</volume>
        <issue>6</issue>
        <fpage>6918</fpage>
        <lpage>6929</lpage>
        <pub-id pub-id-type="doi">10.3892/ol.2018.9523</pub-id>
        <pub-id pub-id-type="pmid">30546424</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-52">
      <label>Wong &amp; Wang (2015)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wong</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>miRDB: an online resource for microRNA target prediction and functional annotations</article-title>
        <source>Nucleic Acids Research</source>
        <year>2015</year>
        <volume>43</volume>
        <issue>D1</issue>
        <fpage>D146</fpage>
        <lpage>D152</lpage>
        <pub-id pub-id-type="doi">10.1093/nar/gku1104</pub-id>
        <pub-id pub-id-type="pmid">25378301</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-53">
      <label>Xie et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xie</surname>
            <given-names>ZC</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>JC</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>LJ</given-names>
          </name>
          <name>
            <surname>Gan</surname>
            <given-names>BL</given-names>
          </name>
          <name>
            <surname>Wen</surname>
            <given-names>DY</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>SH</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>HB</given-names>
          </name>
        </person-group>
        <article-title>Exploration of the diagnostic value and molecular mechanism of miR‑1 in prostate cancer: a study based on meta‑analyses and bioinformatics</article-title>
        <source>Molecular Medicine Reports</source>
        <year>2018</year>
        <volume>18</volume>
        <issue>6</issue>
        <fpage>5630</fpage>
        <lpage>5646</lpage>
        <pub-id pub-id-type="doi">10.3892/mmr.2018.9598</pub-id>
        <pub-id pub-id-type="pmid">30365107</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-54">
      <label>Xu et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Pan</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p</article-title>
        <source>Molecular Cancer</source>
        <year>2018</year>
        <volume>17</volume>
        <issue>1</issue>
        <fpage>141</fpage>
        <pub-id pub-id-type="doi">10.1186/s12943-018-0894-x</pub-id>
        <pub-id pub-id-type="pmid">30266084</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-55">
      <label>Xu et al. (2014)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Fang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Sun</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhan</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>MiR-338-3p inhibits hepatocarcinoma cells and sensitizes these cells to sorafenib by targeting hypoxia-induced factor 1α</article-title>
        <source>PLOS ONE</source>
        <year>2014</year>
        <volume>9</volume>
        <issue>12</issue>
        <elocation-id>e115565</elocation-id>
        <pub-id pub-id-type="doi">10.1371/journal.pone.0115565</pub-id>
        <pub-id pub-id-type="pmid">25531114</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-56">
      <label>Yang et al. (2018a)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Du</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>LncRNA HOTAIR contributes to the malignancy of hepatocellular carcinoma by enhancing epithelial-mesenchymal transition via sponging miR-23b-3p from ZEB1</article-title>
        <source>Gene</source>
        <year>2018a</year>
        <volume>670</volume>
        <fpage>114</fpage>
        <lpage>122</lpage>
        <pub-id pub-id-type="doi">10.1016/j.gene.2018.05.061</pub-id>
        <pub-id pub-id-type="pmid">29778425</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-57">
      <label>Yang et al. (2018b)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yang</surname>
            <given-names>X-Y</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Ma</surname>
            <given-names>S-L</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>M-C</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>A-J</given-names>
          </name>
        </person-group>
        <article-title>Decreased expression of ZWINT is associated with poor prognosis in patients with HCC after surgery</article-title>
        <source>Technology in Cancer Research &amp; Treatment</source>
        <year>2018b</year>
        <volume>17</volume>
        <issue>2</issue>
        <fpage>1533033818794190</fpage>
        <pub-id pub-id-type="doi">10.1177/1533033818794190</pub-id>
        <pub-id pub-id-type="pmid">30198401</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-58">
      <label>Yin et al. (2012)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yin</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Hu</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Shen</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Flatow</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>You</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>MicroRNA-217 promotes ethanol-induced fat accumulation in hepatocytes by down-regulating SIRT1</article-title>
        <source>Journal of Biological Chemistry</source>
        <year>2012</year>
        <volume>287</volume>
        <issue>13</issue>
        <fpage>9817</fpage>
        <lpage>9826</lpage>
        <pub-id pub-id-type="doi">10.1074/jbc.M111.333534</pub-id>
        <pub-id pub-id-type="pmid">22308024</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-59">
      <label>Ying et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ying</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Liang</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Cai</surname>
            <given-names>X</given-names>
          </name>
        </person-group>
        <article-title>Overexpression of Zwint predicts poor prognosis and promotes the proliferation of hepatocellular carcinoma by regulating cell-cycle-related proteins</article-title>
        <source>OncoTargets and Therapy</source>
        <year>2018</year>
        <volume>11</volume>
        <fpage>689</fpage>
        <lpage>702</lpage>
        <pub-id pub-id-type="doi">10.2147/OTT.S152138</pub-id>
        <pub-id pub-id-type="pmid">29440916</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-60">
      <label>You et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>You</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Tan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Gong</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Dai</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Bie</surname>
            <given-names>P</given-names>
          </name>
        </person-group>
        <article-title>MicroRNA-216b-5p functions as a tumor-suppressive RNA by targeting TPT1 in pancreatic cancer cells</article-title>
        <source>Journal of Cancer</source>
        <year>2017</year>
        <volume>8</volume>
        <issue>14</issue>
        <fpage>2854</fpage>
        <lpage>2865</lpage>
        <pub-id pub-id-type="doi">10.7150/jca.18931</pub-id>
        <pub-id pub-id-type="pmid">28928875</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-61">
      <label>Zeng et al. (2018)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zeng</surname>
            <given-names>J-F</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>Z-L</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Y-M</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>J-J</given-names>
          </name>
          <name>
            <surname>Tong</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>D-H</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>Z-S</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>miR-23b-3p and miR-125b-5p downregulate apo(a) expression by targeting Ets1 in HepG2 cells</article-title>
        <source>Cell Biology International</source>
        <year>2018</year>
        <volume>42</volume>
        <issue>3</issue>
        <fpage>313</fpage>
        <lpage>323</lpage>
        <pub-id pub-id-type="doi">10.1002/cbin.10896</pub-id>
        <pub-id pub-id-type="pmid">29064597</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-62">
      <label>Zhang et al. (2016a)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Cao</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma</article-title>
        <source>Tumor Biology</source>
        <year>2016a</year>
        <volume>37</volume>
        <issue>2</issue>
        <fpage>2379</fpage>
        <lpage>2385</lpage>
        <pub-id pub-id-type="doi">10.1007/s13277-015-4052-4</pub-id>
        <pub-id pub-id-type="pmid">26373735</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-63">
      <label>Zhang et al. (2019a)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>He</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Ouyang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>The competitive endogenous RNA regulatory network reveals potential prognostic biomarkers for overall survival in hepatocellular carcinoma</article-title>
        <source>Cancer Science</source>
        <year>2019a</year>
        <volume>110</volume>
        <issue>9</issue>
        <fpage>2905</fpage>
        <lpage>2923</lpage>
        <pub-id pub-id-type="doi">10.1111/cas.14138</pub-id>
        <pub-id pub-id-type="pmid">31335995</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-64">
      <label>Zhang et al. (2017)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Han</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Liao</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>miR-217 suppresses proliferation, migration, and invasion promoting apoptosis via targeting MTDH in hepatocellular carcinoma</article-title>
        <source>Oncology Reports</source>
        <year>2017</year>
        <volume>37</volume>
        <issue>3</issue>
        <fpage>1772</fpage>
        <lpage>1778</lpage>
        <pub-id pub-id-type="doi">10.3892/or.2017.5401</pub-id>
        <pub-id pub-id-type="pmid">28184926</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-65">
      <label>Zhang et al. (2016b)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Zeng</surname>
            <given-names>X-C</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Fu</surname>
            <given-names>B-S</given-names>
          </name>
          <name>
            <surname>Guo</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yi</surname>
            <given-names>H-M</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>W-J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>G-H</given-names>
          </name>
        </person-group>
        <article-title>Down-regulation of microRNA-338-3p promoted angiogenesis in hepatocellular carcinoma</article-title>
        <source>Biomedicine &amp; Pharmacotherapy</source>
        <year>2016b</year>
        <volume>84</volume>
        <fpage>583</fpage>
        <lpage>591</lpage>
        <pub-id pub-id-type="doi">10.1016/j.biopha.2016.09.056</pub-id>
        <pub-id pub-id-type="pmid">27694002</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-66">
      <label>Zhang et al. (2016c)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>T</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Zhu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>T</given-names>
          </name>
        </person-group>
        <article-title>Long noncoding RNA SNHG1 predicts a poor prognosis and promotes hepatocellular carcinoma tumorigenesis</article-title>
        <source>Biomedicine &amp; Pharmacotherapy</source>
        <year>2016c</year>
        <volume>80</volume>
        <fpage>73</fpage>
        <lpage>79</lpage>
        <pub-id pub-id-type="doi">10.1016/j.biopha.2016.02.036</pub-id>
        <pub-id pub-id-type="pmid">27133041</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-67">
      <label>Zhang et al. (2019b)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>PF</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Wu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Liu</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Huang</surname>
            <given-names>XY</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>XM</given-names>
          </name>
          <name>
            <surname>Ke</surname>
            <given-names>AW</given-names>
          </name>
        </person-group>
        <article-title>LncRNA SNHG3 induces EMT and sorafenib resistance by modulating the miR-128/CD151 pathway in hepatocellular carcinoma</article-title>
        <source>Journal of Cellular Physiology</source>
        <year>2019b</year>
        <volume>234</volume>
        <issue>3</issue>
        <fpage>2788</fpage>
        <lpage>2794</lpage>
        <pub-id pub-id-type="doi">10.1002/jcp.27095</pub-id>
        <pub-id pub-id-type="pmid">30132868</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-68">
      <label>Zhang et al. (2016d)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Ying</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>F</given-names>
          </name>
        </person-group>
        <article-title>Expression of long non-coding RNA (lncRNA) small nucleolar RNA host gene 1 (SNHG1) exacerbates hepatocellular carcinoma through suppressing miR-195</article-title>
        <source>Medical Science Monitor</source>
        <year>2016d</year>
        <volume>22</volume>
        <fpage>4820</fpage>
        <lpage>4829</lpage>
        <pub-id pub-id-type="doi">10.12659/MSM.898574</pub-id>
        <pub-id pub-id-type="pmid">27932778</pub-id>
      </element-citation>
    </ref>
    <ref id="ref-69">
      <label>Zheng et al. (2019)</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Zheng</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Jiang</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Ge</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Tang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yao</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Qiu</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Yin</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Ni</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Zhao</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>X</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Yang</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>LncRNA SNHG3/miRNA-151a-3p/RAB22A axis regulates invasion and migration of osteosarcoma</article-title>
        <source>Biomedicine &amp; Pharmacotherapy</source>
        <year>2019</year>
        <volume>112</volume>
        <fpage>108695</fpage>
        <pub-id pub-id-type="doi">10.1016/j.biopha.2019.108695</pub-id>
        <pub-id pub-id-type="pmid">30797154</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
